ascopubs.org: Centrally determined PD-L1 among non-eligible for cisplatin-based chemotherapy recurrent/metastatic head and neck patients (R/M HNSCC pts): Pathology outcomes from the NIVOTAX ...
Centrally determined PD-L1 among non-eligible for cisplatin-based chemotherapy recurrent/metastatic head and neck patients (R/M HNSCC pts): Pathology outcomes from the NIVOTAX ...
Kaleido Scope: Dababneh to serve as Section Head, Head and Neck Pathology
Melad Dababneh, M.B.B.S., Assistant Professor, Anatomic Pathology, will serve as section head of Head and Neck Pathology, effective June 1. Dababneh joined the UAB Department of Pathology in 2024 from ...
Head and Neck Pathology is a section within the Division of Anatomic Pathology at UAB that provides comprehensive Head and Neck pathology diagnostic services to UAB Hospital, UAB Hospital-Callahan Eye ...
Head and Neck Pathology with Clinical Correlation 770 pp, Kent United Kingdom, Churchill Livingstone, 2001 ($322.00). This text is well illustrated with numerous clinical photographs as well as both ...
Nature: Allelic Loss and Tumor Pathology in Head and Neck Squamous Cell Carcinoma
Allelic Loss and Tumor Pathology in Head and Neck Squamous Cell Carcinoma
Head and neck lymphedema is typically managed with a combination of therapies to help reduce swelling and skin effects. The most common treatment for head and neck lymphedema is called complete ...
A PD-L1 score for head and neck cancer helps guide treatment decisions, including when immunotherapy may be used. Here’s what your results mean.
Frontiers: AI & Machine Learning in the Diagnosis and Care of Head and Neck Cancers
Head and neck cancers represent a biologically heterogeneous group of malignancies requiring accurate diagnosis, staging, and risk stratification for ...
AI & Machine Learning in the Diagnosis and Care of Head and Neck Cancers